1. Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health

   • Annabella Vitalone
   • Francesca Menniti-Ippolito
   • Gabriela Mazzanti

   Review Article 18 January 2011 Pages: 215 - 224

2. Power estimation using a population pharmacokinetics model with optimal design by clinical trial simulations: application in pharmacokinetic drug–drug interaction studies

   • Shuying Yang
   • Misba Beerahee

   Clinical Trial 02 December 2010 Pages: 225 - 233

   

3. EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis

   • Peng Chen
   • Long Wang
   • Zui Zou

   Clinical Trial 05 January 2011 Pages: 235 - 243

   

4. Three years of paediatric regulation in the European Union

   • Thorsten M. Olski
   • Simona F. Lampus
   • Agnes Saint Raymond

   Special Article 01 February 2011 Pages: 245 - 252

   

5. Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients

   • Maud Berge
   • Romain Guillemain
   • Marie-Anne Loriot

   Pharmacogenetics 31 October 2010 Pages: 253 - 260

   

6. CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualisation in H. pylori eradication

   • Michael B. Ward
   • David J. R. Foster

   Pharmacogenetics 16 November 2010 Pages: 261 - 266

   

7. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers

   • Anny Fortin
   • Roger K. Verbeeck
   • Frans H. Jansen

   Pharmacokinetics and Disposition 15 October 2010 Pages: 267 - 275

   

8. Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers

   • John P. Sabo
   • Xiuyu (Julie) Cong
   • Thomas R. MacGregor

   Pharmacokinetics and Disposition 12 October 2010 Pages: 277 - 281

9. Adverse events following immunization in children: retrospective analysis of spontaneous reports over a decade

   • Lise Aagaard
   • Erik Wind Hansen
   • Ebba Holme Hansen

   Pharmacoepidemiology and Prescription 16 November 2010 Pages: 283 - 288

   

10. Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy

    • Giovanni Corrao
    • Silvana Antonietta Romio
    • Marina Scavini

    Pharmacoepidemiology and Prescription 19 November 2010 Pages: 289 - 299

    

11. Primary-care prescribing of anti-osteoporotic-type medications following hospitalisation for fractures

    • Bernie M. McGowan
    • Kath Bennett
    • Miriam C. Casey

    Pharmacoepidemiology and Prescription 23 November 2010 Pages: 301 - 308

    

12. Interaction between acetaminophen and warfarin in adults receiving long-term oral anticoagulants: a randomized controlled trial

    • Qian Zhang
    • Claire Bal-dit-Sollier
    • Isabelle Mahé

    Short Communication 30 December 2010 Pages: 309 - 314

    

13. Drug-to-drug interaction between sodium valproate and trihexyphenidyl in a child with extrapyramidal cerebral palsy and epilepsy

    • Marta De Rinaldis
    • Leonarda Gennaro
    • Antonio Trabacca

    Letter to the Editors 20 October 2010 Pages: 315 - 316

14. Cephalosporin-induced recurrent aplastic anemia

    • Jimin Han
    • Hyojeong Lee
    • Tae-Bum Kim

    Letter to the Editors Open access 12 October 2010 Pages: 317 - 318

    

15. Earlier discovery of pregabalin’s dependence potential might have been possible

    • Ola Caster
    • I. Ralph Edwards
    • Marie Lindquist

    Letter to the Editors 23 October 2010 Pages: 319 - 320